Vaccine for adolescents and adults against whooping cough, diphtheria, tetanus
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new combination vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and helps the body build immunity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 10 years of age or older.
- You have not had a vaccine containing diphtheria, tetanus, or whooping cough in the last 3 years (if 10-11) or 5 years (if 12+).
- You are generally healthy, with no serious medical conditions like heart disease, uncontrolled high blood pressure, or immune problems.
- If you can become pregnant, you must use effective birth control before and for 6 months after the study vaccine.
- You have no history of allergic reactions to vaccines, or severe allergies to any medication.
- You are not currently sick with a fever or infection, and have not had a cough lasting 14 days or more in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.
This trial tests a reduced-dose vaccine that protects against diphtheria, tetanus, and whooping cough (pertussis). It is designed for people 6 years and older who have not recently received other vaccines and are generally healthy.
This study is checking how long the protection from an earlier vaccine (which combined protection against whooping cough, diphtheria, and tetanus) lasts. If you took part in that earlier trial, this follow-up will help see if you still have protection.
This trial tests a combined vaccine that protects against five diseases (diphtheria, tetanus, whooping cough, polio, and Hib) in 2-month-old babies who have already received 4 doses. It aims to check the vaccine's safety and how well it builds immunity.
This study tests whether giving pregnant women a special tetanus, diphtheria, and pertussis vaccine (TdaP2gen) helps protect their babies from these diseases. Researchers will follow mothers and infants for up to 18 months to measure how well the vaccine works.
This study tests when during pregnancy it is best to get the Tdap (whooping cough) vaccine. It aims to protect both mother and baby from whooping cough in the first months after birth.
Hear when a new Pertussis (Whooping Cough) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.